Biotech Blueprint | Katerina Roznik | Substack

HIV Breakthrough & Gene Editing Deals — This Week in Biotech #57

Gilead’s HIV breakthrough, Lilly’s $1.3B gene editing deal, and FDA reform efforts (June 13–19, 2025).

READ THE LATEST

Podcasts

Social Media

The latest from

Katerina Roznik

HIV Breakthrough & Gene Editing Deals — This Week in Biotech #57

Recommendations

The Biotech Capital Compass

The Biotech Capital Compass

The Biotech Capital Compass

Bio Breakdowns

Adu Subramanian

Recent posts

Biotech Caught Between AI Momentum and Political Turbulence — This Week in Biotech #56

Novo bets on AI drug discovery, RFK Jr. reshapes the CDC, and Congress targets $5B in pharma ad spending. Catch up on the latest biotech breakthroughs…

Jun 13 •

Katerina Roznik

and

Erin Mihealsick

ASCO Breakthroughs, Gene Therapy Stumbles, and Omada's IPO debut — This Week in Biotech #55

Industry recap: What shaped biotech and pharma from May 30 to June 7, 2025

Jun 9 •

Katerina Roznik

6:07

This Week in Biotech #55

Catch up on the latest biotech breakthroughs and upcoming trends (May 30 - June 5, 2025).

Jun 6 •

Katerina Roznik

and

Erin Mihealsick

CRISPR Setbacks, Vaccine Policy Reversed, and an Oral Antibiotic Breakthrough — This Week in Biotech #54

Biotech & Pharma news covering May 24-30, 2025

Jun 2 •

Katerina Roznik

5:56

This Week in Biotech #54

Catch up on the latest biotech breakthroughs and upcoming trends (May 23-29, 2025).

May 30 •

Katerina Roznik

and

Erin Mihealsick

Biotech Blueprint

Biotech Blueprint

Biotech & pharma news, stocks, science, startups

Top posts

The future of mRNA: companies and trials to watch in 2025

Dec 27, 2024 • Katerina Roznik

Key drugs to keep an eye on in 2025

Jan 4 • Katerina Roznik

New contenders, old headwinds: global biotech looks to China

May 7 • Katerina Roznik and Erin Mihealsick

What a global trade fight means for biotech

Apr 7 • Katerina Roznik

This Week in Biotech #49

Apr 25 • Katerina Roznik and Erin Mihealsick

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts